SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,339 | -48.9% | 29,134 | +2.8% | 0.00% | 0.0% |
| Q2 2023 | $135,701 | -17.1% | 28,330 | -1.9% | 0.00% | 0.0% |
| Q1 2023 | $163,750 | +4.4% | 28,880 | +3.1% | 0.00% | -50.0% |
| Q4 2022 | $156,845 | -9.3% | 28,008 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $173,000 | +188.3% | 26,952 | +54.7% | 0.00% | +100.0% |
| Q2 2022 | $60,000 | -54.9% | 17,423 | -6.4% | 0.00% | 0.0% |
| Q1 2022 | $133,000 | -13.6% | 18,621 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $154,000 | +18.5% | 18,514 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $130,000 | -70.7% | 18,729 | +0.7% | 0.00% | -75.0% |
| Q2 2021 | $444,000 | +15.9% | 18,603 | +0.0% | 0.00% | +33.3% |
| Q1 2021 | $383,000 | -12.2% | 18,594 | +4.4% | 0.00% | -25.0% |
| Q4 2020 | $436,000 | – | 17,807 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |